Cüneyt Uysal, Yakup Albayrak ABSTRACT It is well known that some drugs and neurodegenerative processes, such asParkinson’s disease, can cause extrapyramidal side effects (1). Extrapyramidal symptoms (ES) may be drug-induced and due affect tolerance and compliance (2). ES includes akathisia, parkinsonian symptoms (e.g. tremor, bradykinesia and muscle rigidity) and impaired involuntary movements (e.g. acute dystonia […]
